NFKB1 and heart failure: SIRT1 was found to improve cardiac function, reduce ventricular mass, and decrease apoptosis in cardiomyocytes by inhibiting the acetylation of NF-κB p65, leading to a decrease in the expression of NF-κB p65, which ameliorates heart failure [96].